Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Infection and Immunity|April 9, 2001
Search for correlates of protective immunity conferred by anthrax vaccineS Reuveny, M D White, Y Y Adar, et al.
Chemico-Biological Interactions|July 27, 1999
A preliminary comparison of structural models for catalytic intermediates of acetylcholinesteraseI Silman, C B Millard, A Ordentlich, et al.
Infection and Immunity|January 24, 2003
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccinesO Gat, I Inbar, R Aloni-Grinstein, et al.
Journal of Interferon Research|April 1, 1989
Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurificationD Kobiler, H Grosfeld, M Leitner, et al.
The Journal of Biological Chemistry|August 15, 1993
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocketA Ordentlich, D Barak, C Kronman, et al.
The Journal of Biological Chemistry|September 5, 1992
Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide foldingA Shafferman, C Kronman, Y Flashner, et al.
Infection and Immunity|July 23, 2003
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigensN Ariel, A Zvi, K S Makarova, et al.
Journal of Virology|February 1, 1992
Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activityH Grosfeld, S Lustig, Y Gozes, et al.
FEBS Letters|May 5, 1997
Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometryR Barak, A Ordentlich, D Barak, et al.
Vaccine|July 26, 2005
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin componentsI Mendelson, O Gat, R Aloni-Grinstein, et al.
Pageof 8